Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)

CUSIP: 29384C108

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 7 signals
Share change
-1,320,277
Put/Call ratio
102%
SEC-reported price per share
$5.80
Number of holders
114
Value change
-$9,410,304
Number of buys
72
Open additional details 1 more signal available
Number of sells
44
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
38,346,880

Security key

29384C108

Report period

Q3 2025

Institutions

114

Top holders

10

Ownership snapshot

Top reported holders of TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ROCHE FINANCE LTD
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G 13F Lead comparable stake: 6.9% 13D/G row: ROCHE FINANCE LTD Showing 1-6 of 15 holder rows.

Quick read

ROCHE FINANCE LTD leads the comparable SEC ownership view at 6.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ROCHE FINANCE LTD's linked filing trail.
Comparable ownership Top 5
ROCHE FINANCE LTD 6.9%
BlackRock, Inc. 5.3%
JANUS HENDERSON GROUP PLC 4%
PRICE T ROWE ASSOCIATES INC /MD/ 0.9%
BAKER BROS. ADVISORS LP 13%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ROCHE FINANCE LTD
13D/G
6.9%
$23,019,270
2,569,115 shares
$0 31 Dec 2024
BlackRock, Inc.
13D/G 13F
Company
5.3%
$17,691,090
1,974,452 shares
$0 31 Dec 2024
JANUS HENDERSON GROUP PLC
13F 13D/G
Company
4%
from 13D/G
$10,207,796
1,521,281 shares
30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/
13F 13D/G
Company · T. Rowe Price Associates, Inc.
0.9%
from 13D/G
$17,255,000
2,567,478 shares
30 Jun 2025
BAKER BROS. ADVISORS LP
13F
Company
13F
13%
$32,698,304
4,865,819 shares
30 Jun 2025
MPM ASSET MANAGEMENT LLC
13F
Company
13F
11%
$29,440,737
4,381,062 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
114
Shares
28,408,651
Rows available
114
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
105
Q3 2025 holders
114
Holder diff
9
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .